Recruiting NCT04192422
DiGESTnewborn Study
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: no intervention.
- Who it may be relevant to
- Registry conditions: GDM, Hypoglycemia. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United Kingdom
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Glucose Control and Metabolic Adaptation in Offspring of Women With Gestational Diabetes Recruited to the DiGest Study
Overview
We wish to study the effect of a mothers sugar (glucose) control during pregnancy on her baby's sugar control after birth.
Interventions
- Other no intervention
This is a cohort study no intervention
Primary outcome measures
- Neonatal sensor glucose time in target [Time frame: From sensor insertion for up to the first 7 days of life]
Eligibility criteria
Inclusion criteria
- mothers and their babies who have been enrolled in DiGest Trial and who have provided informed consent
Exclusion criteria
- none
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
United Kingdom · 1 center
- Addenbrookes Hospital — Cambridge
Identifiers
NCT: NCT04192422 · DiGestnewborn v2.0 24.10.2019